At a glance
- Originator Pfizer
- Class Anti-inflammatories; Antiallergics; Antiasthmatics; Antihistamines; Small molecules
- Mechanism of Action Histamine release inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Allergic rhinitis; Asthma; Cancer; Crohn's disease; Ischaemic heart disorders; Peptic ulcer; Ulcerative colitis
Most Recent Events
- 28 Jun 1999 Discontinued-I for Allergic rhinitis in USA (Unknown route)
- 28 Jun 1999 Discontinued-I for Ischaemic heart disorders in USA (Unknown route)
- 28 Jun 1999 Discontinued-II for Asthma in USA (Unknown route)